Articles published by Xenon Pharmaceuticals Inc.
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
Xenon Expands Leadership Team with Matthew D. Ronsheim, Ph.D. as Chief Operating Officer
August 12, 2024
Via GlobeNewswire
Tickers
XENE
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
Xenon Reports Q2 2024 Financial Results and Business Update
August 08, 2024
Via GlobeNewswire
Tickers
XENE
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
Xenon to Report Q2 2024 Financial Results on August 8, 2024
August 01, 2024
Via GlobeNewswire
Tickers
XENE
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
Via GlobeNewswire
Tickers
XENE
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting
April 16, 2024
Via GlobeNewswire
Tickers
XENE
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
April 10, 2024
Via GlobeNewswire
Tickers
XENE
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference
April 04, 2024
Via GlobeNewswire
Tickers
XENE
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
Via GlobeNewswire
Tickers
XENE
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024
March 05, 2024
Via GlobeNewswire
Tickers
XENE
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2024
January 08, 2024
Via GlobeNewswire
Tickers
XENE
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
Xenon Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
Via GlobeNewswire
Tickers
XENE
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
Via GlobeNewswire
Tickers
XENE
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
Xenon Pharmaceuticals Announces Proposed Public Offering
November 29, 2023
Via GlobeNewswire
Tickers
XENE
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
Xenon Pharmaceuticals Provides Update on Partnered Program with Neurocrine Biosciences
November 09, 2023
Via GlobeNewswire
Tickers
XENE
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
Xenon Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
November 08, 2023
Via GlobeNewswire
Tickers
XENE
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
Via GlobeNewswire
Tickers
XENE
![](https://ml.globenewswire.com/media/8b698873-028e-4d42-99f9-3c49e1f32808/small/xenon-png.png)
Xenon Pharmaceuticals to Present at TD Cowen’s 3rd Annual Novel Mechanisms in Neuropsychiatry Summit
September 14, 2023
Via GlobeNewswire
Tickers
XENE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.